Grace Therapeutics, Inc.: Form 10-Q/A for the period ended Dec 31, 2024
Filed with the SEC on Feb 19, 2025 and accepted by EDGAR at Feb 18, 2025, 20:25 ET.
Sections
No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001140361-25-005051. Last ingested by Listed: Nov 14, 2026, 23:10 ET. Listed shows no prices and gives no investment advice.